Funding
← Back to your selection

Sofinnova Partners

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Sep 17, 2026
Rounds participated in
2
Confirmed lead rounds
1
All roles disclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$99.3M
2 disclosed · full round size, not this investor’s share

By stage

Undisclosed2

By primary sector

Biotech1
Healthtech1

By country

France1
Sweden1

Rounds

2 in this selection
EnginZyme

EnginZyme develops cell-free biomanufacturing technology that uses immobilized enzymes to make chemicals and ingredients through scalable industrial processes.

SEK 75MEquity round
Participant
HighLife

HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.

€80MFinancing round
Lead